You haven't changed your training or your eating, but the shape of your body has. The scale barely moves, yet your waistbands feel different — and something about your recovery, your sleep, and your mood tells you this isn't just "getting older."
If that describes you, you're reading the right thing. This shift is real, it's measurable, and it deserves to be taken seriously — even at 43, and especially at 47. This article is educational and not medical advice, but it will give you the vocabulary and the biomarkers to have a much better conversation with a provider.
The scale is the wrong instrument
Body weight is a single number that hides what's actually happening underneath: the ratio of fat to lean mass, and *where* the fat sits. During the menopause transition, body composition can change even when total weight holds steady. Longitudinal data from the Study of Women's Health Across the Nation (SWAN) show that fat mass tends to accumulate and lean mass tends to decline across the transition, with a measurable acceleration in fat gain in the years surrounding the final menstrual period [1].
The redistribution matters as much as the amount. Research using imaging to separate abdominal fat has found that the proportion of *visceral* fat — the metabolically active fat packed around the organs — rises across the menopause transition, independent of overall aging [2]. That's why the change often reads as "my middle" rather than "my whole body."
For a strength-focused woman, this is the key reframe: you are not necessarily gaining weight. You may be *trading* metabolically favorable lean mass and subcutaneous fat for metabolically riskier visceral fat, and the scale can't tell the difference.
The mechanism: what estradiol was doing all along
Estradiol isn't only a reproductive hormone. It participates in how the body stores fat and handles glucose. As ovarian estradiol production becomes erratic and then declines through perimenopause, several things tend to shift together: fat storage favors the abdomen, insulin sensitivity can decline, and lean mass becomes harder to hold [1][2].
The menopause transition is also independently associated with less favorable changes in lipid particles — particularly a rise in apolipoprotein B (ApoB)-containing particles and LDL, which appears to track the transition itself rather than simply chronological age [3]. In other words, the cardiometabolic picture can move before the calendar would predict it.
None of this means something is wrong with you. It means the hormonal environment that quietly supported your metabolism for decades is changing — and the signs show up in your recovery, your sleep, and your labs before they show up on the scale.
The biomarkers that actually track the change
If the scale is the wrong instrument, what's the right one? These are the markers a provider may consider to understand the *composition* and *metabolic* story, not just the weight:
Waist trend (not a one-time number)
Waist circumference is a practical proxy for abdominal fat and is used in the clinical definition of metabolic syndrome. Thresholds identified by major organizations are ≥88 cm (about 35 inches) for women and ≥102 cm (about 40 inches) for men [4]. The *trend* over months is more informative than any single reading.
Fasting insulin and glucose
Insulin resistance can develop before fasting glucose drifts out of range, so fasting insulin (and the calculated relationship between insulin and glucose) can surface a change earlier than glucose alone. Fasting glucose categories — normal, prediabetes, and diabetes — are defined by the American Diabetes Association [5].
ApoB and a full lipid panel
ApoB counts the number of atherogenic particles and can add information beyond LDL cholesterol alone, which is why it's discussed in cardiovascular prevention guidance [6]. Given the transition-related lipid shifts noted above, this is a marker worth trending across perimenopause [3][6].
Lean mass and function
Numbers on a lab report don't capture strength. Grip strength, how long your recovery takes between hard sessions, and whether you're maintaining lifting performance are functional signals that matter as much as any biomarker for a woman who intends to train through her 50s.
mg/dL · marker = Prediabetes starts
Source: [5] American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Care.
Why "too young" is the wrong answer
Perimenopause is a *transition*, not a switch. It can begin years before the final period, and hormone levels swing rather than glide downward — which is exactly why a single lab value on a single day can look "normal" and still miss what you're experiencing. The Endocrine Society and menopause-focused clinicians describe the transition as a staged process defined largely by menstrual pattern changes and symptoms, not by one hormone reading [7]. Being 43 with a changing cycle, broken sleep, and mood shifts is not "too young" to have this taken seriously.
If you've been dismissed, the most useful move is to shift the conversation from "is my weight a problem" to "here is my waist trend, my fasting insulin, my ApoB, and my recovery — help me interpret them." That's a data conversation a good provider can engage with.
What thoughtful support can and can't promise
Options discussed in this space range from strength training and sleep and protein strategies to, in some cases, prescription hormone therapy or other agents evaluated by a licensed provider. What matters is the honest framing: no responsible provider can promise a specific outcome, a number on the scale, or that any particular therapy is right for you. A prescription — if one is ever appropriate — is a decision made by an independent, licensed provider after reviewing your history and labs.
Some longevity and hormone protocols involve compounded medications. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
The goal for a strength-focused woman isn't a lower number on the scale. It's preserved lean mass, favorable metabolic markers, restored recovery, and function that lets you keep lifting — measured over months, with the right instruments.
Where Velri fits
Velri is a technology and coordination company; it does not provide medical care. Velri can help coordinate the lab work discussed here and connect you with an independent, licensed provider who reviews your results and history, takes perimenopause seriously at your stage, and talks through options as a partner — not a gatekeeper. If a provider determines a prescription is appropriate, it is filled by an independent, licensed pharmacy. Velri coordinates the logistics; the clinical decisions belong to your provider.
This article is educational and is not medical advice. Talk with a licensed provider about your individual situation.
